Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent-Reference-Cited by-同舟云学术

Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent

Published:2008-06 Issue:23 Volume:51 Page:2276-2285
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Gheorghiade Mihai,Blair John E.A.,Filippatos Gerasimos S.,Macarie Cezar,Ruzyllo Witold,Korewicki Jerzy,Bubenek-Turconi Serban I.,Ceracchi Maurizio,Bianchetti Maria,Carminati Paolo,Kremastinos Dimitrios,Valentini Giovanni,Sabbah Hani N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Acute heart failure syndromes: current state and framework for future research;Gheorghiade;Circulation,2005

2. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment;Gheorghiade;Am J Med,2006

3. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure;Gheorghiade;JAMA,2006

4. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology;Nieminen;Eur Heart J,2005

5. HFSA 2006 comprehensive heart failure practice guideline;J Card Fail,2006

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors;European Journal of Heart Failure;2024-02

2. Selective SERCA2a activator as a candidate for chronic heart failure therapy;Journal of Translational Medicine;2024-01-19

3. Istaroxime for Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Diseases;2023-12-17

4. Selective SERCA2a activator as a candidate for chronic heart failure therapy;2023-11-25

5. Istaroxime: A Novel Therapeutic Agent for Acute Heart Failure;Cardiology in Review;2023-10-09